400-6699-1171000

分析测试百科网 认证会员,请放心拨打!

首页> 产品展示> 黄芪甲苷 T4082
普通会员

诚信认证:

工商注册信息已核实!

快速导航
品牌
其他生物化学试剂

黄芪甲苷 T4082

英文名称:Astragaloside
品牌 厂商性质 产地 货期
TargetMol 生产商 美国 现货

性能特点

生化试剂,可用于动物细胞实验

在线咨询 询底价
AI问答
配套的仪器设备? 可以搭配的相关耗材试剂?
产品参数
规格 CAS号 价格 操作
100 mg 17429-69-5 ¥622.00 询底价
1 mL 17429-69-5 ¥280.00 询底价
50 mg 17429-69-5 ¥346.00 询底价
25 mg 17429-69-5 ¥192.00 询底价
200 mg 17429-69-5 ¥1,120.00 询底价
产品介绍

Product Introduction
Bioactivity


英文名: Astragaloside

描述: Astragaloside 是黄芪中的主要活性成分之一。

细胞实验: Cell viability is determined by CCK-8 assay. To be brief, cultured NSCLC cells are seeded into 96-well plates at the density of 4×104 (cells/well). Then 10 μL?well CCK8 solution is added and incubated in dark at 37°C for another 2 h. The absorbance is determined with the wavelength of 490 nm.

激酶实验: Briefly, MDA-MB-231 cells treated as indicated or tumor tissues are harvested and lysed in Mg2+ lysis buffer containing 50 mM Tris (pH 7.5), 10 mM MgCl2, 0.5 M NaCl, and protease inhibitor cocktail. Equal amounts of lysates are incubated with PAK-PBD beads at 4°C for 1 h. PAK-PBD beads are pelleted by centrifugation and washed with ish buffer containing 25 mM Tris (pH 7.5), 30 mM MgCl2, 40 mM NaCl. Active Rac1 is detected by western blotting.

动物实验: Transient cerebral ischemia and reperfusion is prepared by BCCAO, as BCCAO is considered an ideal model to study transient cerebral ischemia and reperfusion injury-mediated inflammatory response. Mice are randomLy divided into the Sham, Model, Astragaloside IV (10 mg/kg) and Astragaloside IV (20 mg/kg) treatment groups. The Astragaloside IV treatment groups are intragastrically administered 7 days before the surgery and terminated on the day of sacrifice. On the day of the surgery, Astragaloside IV is administrated 2 h prior to ischemia. The Sham-operated and Model groups are treated with distilled water. After the mice are anesthetized with an intraperitoneal injection of chloral hydrate (350 mg/kg), the bilateral common carotid arteries are exposed and carefully separated with a small ventral neck incision and occluded twice (20 min each) with ligated surgical silk as described previously with minor modifications. There is a 10 min reperfusion period between the two occlusion periods (ischemia 20 min ? reperfusion 10 min ? ischemia 20 min). Sham-operated mice are subjected to the same surgical operation without the surgical silk ligation. Mouse body temperature is maintained at 37±0.5°C during the surgery with heating equipment until recovery from the anesthesia.

体外活性: Astragaloside IV (10, 20, 40 ng/mL) inhibits NSCLC cell growth, whereas low concentrations of astragaloside IV (1, 2.5, 5 ng/mL) has no obvious cytotoxicity on cell viability. Moreover, combined treatment with astragaloside IV significantly increases chemosensitivity to cisplatin in NSCLC cells. On the molecular level, astragaloside IV co-treatment significantly inhibits the mRNA and protein levels of B7-H3 in the presence of cisplatin. Astragaloside IV inhibits the viability and invasive potential of MDA-MB-231 breast cancer cells, suppresses the activation of the mitogen activated protein kinase (MAPK) family members ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2 and -9.

体内活性: Astragaloside IV (10, 20 mg/kg, p.o.) exhibits a potent ability to prevent cognitive deficits induced by transient cerebral ischemia and reperfusion. Astragaloside IV (10 mg/kg) and Astragaloside IV (20 mg/kg) can significantly decrease the levels of these cytokines compared to the Model group. Astragaloside IV significantly inhibits the level of TLR4 and its downstream proteins, suggesting that both MyD88-dependent and -independent pathways play important roles in the anti-inflammatory effects of Astragaloside IV. Astragaloside IV attenuates NLRP3 and cleaved-caspase-1 expression, and reduces Iba1 protein expression[1]. In the mice model, the high-dose astragaloside IV group has a significant increase in the 48-hour survival rate [60% (9/15) vs 13.3% (2/15), P < 0.05], significant reductions in the serum ALT and AST levels (P < 0.01), and significant reductions in liver histopathological indices and the degree of apoptosis of hepatocytes (P < 0.01), as well as a significant reduction in the content of MDA in liver homogenate (P < 0.01) and a significant increase in the activity of SOD.

存储条件: keep away from direct sunlightPowder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (78.06 mM)


关键字: Astragaloside

相关产品: isomer-CM 352 | Prinomastat | Ilomastat | Lucidenic acid C | Marimastat | 2-Methoxystypandrone | Pimaric acid | CL-82198 | PNU-248686A | Stigmasterol

黄芪甲苷 T4082信息由TargetMol中国为您提供,如您想了解更多关于黄芪甲苷 T4082报价、型号、参数等信息,欢迎来电或留言咨询。

注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途

店铺推荐
  • 品牌:TargetMol
    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    蛋白酶抑制剂 Cocktail (EDTA-Free, 100× in DMSO) C0001

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    磷酸酶抑制剂 Cocktail I (100× ddH2O) C0002

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    磷酸酶抑制剂 Cocktail II (100× DMSO) C0003

    询价
  • 品牌:TargetMol
    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    磷酸酶抑制剂 Cocktail III (2 Tubes, 100x) C0004

    询价
  • 品牌:TargetMol
    Cell Counting Kit-8 (CCK-8) C0005

    Cell Counting Kit-8 (CCK-8) C0005

    询价
  • 品牌:TargetMol
    SYBR Green qPCR Master Mix (No ROX) C0006

    SYBR Green qPCR Master Mix (No ROX) C0006

    询价